BerandaFBIOP • NASDAQ
add
Fortress Biotech 9 375 Cumulative Redeemable Perpetual Pref Shs Series A
Tutup sebelumnya
$13,59
Rentang hari
$13,33 - $13,82
Rentang tahun
$4,72 - $14,64
Kapitalisasi pasar
80,83Â jt USD
Volume Rata-Rata
24,56Â rb
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 16,08Â jt | 6,34% |
Biaya operasional | 27,70Â jt | 25,65% |
Penghasilan bersih | -3,94Â jt | 41,80% |
Margin laba bersih | -24,49 | 45,26% |
Penghasilan per saham | — | — |
EBITDA | -3,63Â jt | 79,79% |
Tarif pajak efektif | 13,13% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 79,38Â jt | 38,63% |
Total aset | 185,55Â jt | 28,65% |
Total liabilitas | 123,36Â jt | -15,43% |
Total ekuitas | 62,18 jt | — |
Saham yang beredar | 32,20 jt | — |
Harga terhadap nilai buku | 8,54 | — |
Tingkat pengembalian aset | -6,53% | — |
Tingkat pengembalian modal | -9,11% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Des 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -3,94Â jt | 41,80% |
Kas dari operasi | -12,54Â jt | 2,81% |
Kas dari investasi | 0,00 | 100,00% |
Kas dari pembiayaan | 5,71Â jt | -77,88% |
Perubahan kas bersih | -6,84Â jt | -225,42% |
Arus kas bebas | -39,92Â jt | -131,34% |
Tentang
Fortress Biotech Inc., commonly known as Fortress Bio, is a biopharmaceutical company that acquires, develops, and commercializes innovative pharmaceutical and biotechnology products. Led by CEO Lindsay A. Rosenwald, M.D., Fortress and most of its subsidiary companies are headquartered in Bay Harbor Islands, Florida. Wikipedia
Didirikan
2006
Kantor pusat
Situs
Karyawan
101
